Metraipolis › archive › dc_402f602aa85d

Microvascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review of Retinopathy and Nephropathy Evidence — Europe PMC PMID:41141089

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41141089
DOI
10.7759/cureus.92976
License (as archived)
solo-consultazione
Archived
2026-11-09T20:10:11.419Z
SHA-256 of the archived text
27debe8e90a4cdb62a602e166449aad5b563ea9f830e35c8f3773e282e4ad785
Stable URL of this page
https://metraipolis.com/documento/dc_402f602aa85d

How to cite

Microvascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review of Retinopathy and Nephropathy Evidence — Europe PMC PMID:41141089 — Europe PMC (en), https://europepmc.org/article/MED/41141089 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_402f602aa85d (Metraipolis archive dc_402f602aa85d, sha256 27debe8e90a4cdb62a602e166449aad5b563ea9f830e35c8f3773e282e4ad785)
BibTeX
@misc{dc402f602aa85d,
  title = {Microvascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review of Retinopathy and Nephropathy Evidence — Europe PMC PMID:41141089},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41141089},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_402f602aa85d; sha256 27debe8e90a4cdb62a602e166449aad5b563ea9f830e35c8f3773e282e4ad785},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41141089. Agents can read the archived copy with the MCP tool read_document.